Bill Ackman’s $64 billion UMG bid hinges on one unpredictable billionaire
ADAR1 Capital Management, LLC, a 10% owner and director of NextCure, Inc. (), acquired common stock totaling $1,624,120 through multiple transactions on July 30 and July 31, 2026. The investment firm purchased a total of 329,153 shares of NextCure common stock. The
